Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Lifecare AS ( (DE:LFC0) ) has shared an update.
Lifecare ASA has reminded investors that the exercise period for its 129,000,033 Series 1 warrants, issued in connection with a January 2026 rights issue, expires today at 16:30 CET, with each warrant allowing subscription for one new share at NOK 0.3342. Any warrants not exercised by the deadline will lapse without compensation, potentially diluting non-participating holders and underscoring the importance of timely action for existing shareholders.
The warrants can be exercised via an exercise form submitted to the issue managers or through the VPS online subscription system, with detailed procedures available on the managers’ websites. The transaction is not being offered in restricted jurisdictions, and the managers emphasize they act solely for Lifecare in the rights issue, with the announcement serving as information only rather than investment advice or a securities offering.
More about Lifecare AS
Lifecare ASA is a medical sensor company developing technology for sensing and monitoring various body analytes, with a primary focus on next-generation continuous glucose monitoring systems. The company’s osmotic pressure-based sensor technology is designed to detect and track a wide range of molecules in humans and pets, targeting advanced diagnostic and monitoring applications.
Average Trading Volume: 3,951,568
Current Market Cap: NOK114.6M
Find detailed analytics on LFC0 stock on TipRanks’ Stock Analysis page.